v3.26.1
Note 2 - Summary of Significant Accounting Policies (Details Textual)
3 Months Ended
Oct. 21, 2025
Mar. 31, 2026
USD ($)
shares
Dec. 31, 2025
USD ($)
Cash, Uninsured Amount   $ 17,799,219 $ 7,580,820
Research and Development Assets, Current   1,503,207 1,802,228
Impairment, Long-Lived Asset, Held-for-Use   0  
Derivative Liability   $ 22,500 $ 22,500
Minimum [Member]      
Property, Plant and Equipment, Useful Life (Year)   3 years  
Maximum [Member]      
Property, Plant and Equipment, Useful Life (Year)   5 years  
Share-Based Payment Arrangement, Option [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares   1,325,388  
Restricted Stock Units (RSUs) [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares   85,179  
Reverse Stock Split [Member]      
Stockholders' Equity Note, Stock Split, Conversion Ratio 50